UA-MHC H-2D(b)/EGSRNQDWL gp100四聚体-APC标记在抗原特异性T细胞检测中的应用

I. Technical Background of Antigen-Specific T Cell Detection

T cell-mediated immune responses play a central role in tumor immune surveillance and autoimmune regulation. Accurate identification and quantitative analysis of antigen-specific CD8+ T cells are critical technical steps for deciphering immune response mechanisms and evaluating immunotherapy efficacy. Traditional detection methods such as enzyme-linked immunospot (ELISPOT) assay and intracellular cytokine staining (ICS) can reflect T cell functional states but cannot directly determine the frequency and phenotype of antigen-specific T cells. The establishment of major histocompatibility complex (MHC) tetramer technology has provided a reliable tool for direct visualization and quantitative analysis of antigen-specific T cells, advancing immune monitoring techniques.

II. Core Principle of MHC Tetramer Technology

MHC tetramer technology is based on the specific recognition between T cell receptors (TCR) and MHC-antigen peptide complexes. Biotinylated monomeric MHC-antigen peptide complexes are mixed with fluorescently labeled streptavidin at an optimized ratio. The four biotin-binding sites of streptavidin can simultaneously bind four MHC monomers, forming a stable tetramer structure. This structure significantly enhances the binding affinity to antigen-specific TCRs, enabling stable labeling of antigen-specific CD8+ T cells. Combined with flow cytometry, labeled cells can be precisely characterized and quantified. Further staining with other surface markers allows in-depth analysis of the phenotypic features and differentiation states of antigen-specific T cells.

III. Construction and Characteristics of H-2D(b)/EGSRNQDWL gp100 Tetramer

The H-2D(b)/EGSRNQDWL gp100 tetramer is a specific detection tool assembled from the mouse H-2D(b) MHC class I molecule and the EGSRNQDWL peptide derived from the melanoma-associated antigen gp100. This tetramer is labeled with APC fluorescence, offering high sensitivity, specificity, and excellent photostability. The APC fluorophore features high quantum yield, suitable excitation wavelength, and compatibility with multicolor flow cytometry. This tetramer can specifically recognize CD8+ T cells with TCRs targeting the gp100 antigen peptide, making it widely applicable for detecting and analyzing antigen-specific CD8+ T cells in mouse tumor models. It serves as a standardized tool for tumor immunology research.

IV. Application Value in Tumor Immunology Research

gp100 is a melanoma-associated antigen of significant importance in tumor immunotherapy research. The H-2D(b)/EGSRNQDWL gp100 tetramer plays a key role in studying melanoma-specific T cell responses. Using gp100-expressing melanoma cell lines such as B16-gp100 to establish tumor-bearing mouse models, researchers can employ this tetramer to monitor the distribution, expansion dynamics, and functional maintenance of tumor-specific CD8+ T cells in peripheral blood, lymphoid organs, and tumor tissues. This method enables direct detection of antigen-specific T cell frequency in tumor-infiltrating lymphocytes (TILs), providing critical data for understanding T cell functional exhaustion in the tumor immune microenvironment.

V. Applications in Immunotherapy Efficacy Evaluation

Immune checkpoint blockade therapy and adoptive T cell therapy have achieved remarkable progress in melanoma treatment. The H-2D(b)/EGSRNQDWL gp100 tetramer provides a direct detection tool for evaluating the immune effects of these therapeutic strategies. During treatment, this tetramer can be used to dynamically monitor changes in the frequency of gp100-specific CD8+ T cells, assessing the extent of T cell expansion induced by therapy. Combined with staining for memory markers (e.g., CD44, CD62L) and activation markers (e.g., CD69, PD-1), it further enables analysis of effector memory T cells, central memory T cells, and exhausted T cell differentiation states, offering key data support for understanding therapeutic mechanisms and optimizing treatment strategies.

VI. Applications in Tumor Vaccine Development

The core goal of tumor vaccine development is to induce durable tumor antigen-specific T cell immune responses. The H-2D(b)/EGSRNQDWL gp100 tetramer provides a standardized tool for evaluating the immunogenicity of tumor vaccines. After vaccination with gp100-containing candidate vaccines, this tetramer can be used to detect the frequency of EGSRNQDWL-specific CD8+ T cells in peripheral blood and lymphoid tissues, assessing the strength and persistence of vaccine-induced T cell responses. By comparing antigen-specific T cell responses induced by different vaccine vectors, adjuvants, and immunization protocols, optimal immunization strategies can be screened, providing preclinical data support for clinical translation of tumor vaccines.

VII. Comparative Advantages Over Other Detection Methods

Compared with traditional functional detection methods, the H-2D(b)/EGSRNQDWL gp100 tetramer-APC conjugate offers multiple advantages. It enables direct detection of antigen-specific T cells without requiring in vitro stimulation or expansion, accurately reflecting the frequency and phenotype of the in vivo T cell repertoire. It can be combined with multiparameter flow cytometry for deep phenotypic analysis, simultaneously detecting multiple surface markers and functional molecules. It exhibits high specificity, low background signals, and objective, reliable results. The method is simple to operate, has a short detection cycle, and is suitable for large-scale sample screening and longitudinal studies. It can also be used in combination with intracellular cytokine staining to simultaneously detect antigen-specific T cell frequency and function, providing more comprehensive immune response information.

VIII. Suppliers of UA-MHC H-2D(b)/EGSRNQDWL gp100 Tetramer-APC Conjugate

Nanjing UA-Bio Technology Co., Ltd. (UA-Bio) has independently developed the "UA-MHC H-2D(b)/EGSRNQDWL gp100 Tetramer-APC Labelled", a high-performance MHC tetramer reagent specifically designed for antigen-specific CD8+ T cell identification and sorting. This product is based on the mouse H-2D(b) MHC class I molecule complexed with the EGSRNQDWL antigen peptide derived from gp100, labeled with APC fluorescence. It aims to accurately and efficiently identify and quantify antigen-specific CD8+ T cells, providing a stable and reliable standardized tool for tumor immunology, infectious immunology, and vaccine development research.

Nanjing UA-Bio Technology Co., Ltd. is committed to providing cutting-edge, high-quality core reagents and tools for immunology, cell therapy, and innovative drug development. For detailed technical parameters, validation data, or specific application inquiries regarding the "UA-MHC H-2D(b)/EGSRNQDWL gp100 Tetramer-APC Labelled" (Catalog No.: UA089047), please feel free to contact us.